In vitro models to study mechanisms involved in cyclosporine A-mediated glomerular contraction

Area of Science:

• Nephrology
• Pharmacology
• Cell Biology

Background:

• Cyclosporin A (CsA) is vital for preventing organ transplant rejection.
• CsA can cause renal side effects, including decreased glomerular filtration rate.
• Mesangial cell tone regulates renal function and is implicated in CsA's nephrotoxicity.

Purpose of the Study:

• To investigate the effects of CsA on isolated glomeruli and mesangial cells in vitro.
• To analyze the roles of intracellular and extracellular mediators in CsA-induced renal effects.
• To understand the mechanisms behind CsA's impact on renal vasoreactivity.

Main Methods:

• Image analysis of isolated glomeruli and mesangial cells.
• Fluorimetric analysis of intracytosolic free calcium and reactive oxygen species (ROS) production.
• Inhibition studies using calcium antagonists, ET-1 antibodies, prostacyclin agonists, and antioxidants.

Main Results:

• CsA caused a concentration- and time-dependent decrease in glomeruli and mesangial cell size.
• CsA significantly increased intracytosolic calcium and hydrogen peroxide (H2O2) production.
• While ET-1 and prostaglandins showed no significant direct changes, ET-1 antibodies and prostacyclin agonists modified CsA-induced contraction. Antioxidants inhibited CsA-induced mesangial cell contraction.

Conclusions:

• CsA disrupts the balance of vasoconstrictive and vasodilator mediators in the kidney.
• Increased intracellular calcium and ROS production are key mechanisms in CsA-induced mesangial cell contraction.
• CsA's nephrotoxicity involves complex interactions affecting renal vasoreactivity.